Related references
Note: Only part of the references are listed.Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis
Masayuki Nagahashi et al.
CANCER RESEARCH (2012)
Fibroblast growth factors and their receptors in cancer
Jorgen Wesche et al.
BIOCHEMICAL JOURNAL (2011)
Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases
Lisa Willis et al.
CANCER RESEARCH (2010)
EGFR signaling in breast cancer: Bad to the bone
John Foley et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Antitumor/Antiestrogenic Effect of the Chemokine Interferon Inducible Protein 10 (IP-10) Involves Suppression of VEGF Expression in Mammary Tissue
Susan M. Aronica et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
The effects of surgery on tumor growth: a century of investigations
R. Demicheli et al.
ANNALS OF ONCOLOGY (2008)
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Eugen Ruckhaeberle et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
Romano Demicheli et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
R. A. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2007)
The role of VEGF and EGFR inhibition: Implications for combining anti-VEGF and anti-EGFR agents
Josep Tabernero
MOLECULAR CANCER RESEARCH (2007)
Tumour angiogenesis: the relevance to surgeons
G. K. Atkin et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2006)
VEGF-C expressing tumor-associated macrophages in lymphnode positive breast cancer: impact on lymphangiogenesis and survival
Sebastian F. Schoppmann et al.
SURGERY (2006)
Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells
ED Feldman et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process
R Demicheli et al.
ANNALS OF ONCOLOGY (2005)
Systemic effects of surgery:: quantitative analysis of circulating basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) in patients with breast cancer who underwent limited or extended surgery
G Curigliano et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Angiogenesis of breast cancer
BP Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
DIR Holmes et al.
GENOME BIOLOGY (2005)
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
IH Benoy et al.
CLINICAL CANCER RESEARCH (2004)
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients
M Retsky et al.
BREAST CANCER RESEARCH (2004)
Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis
DG Duda et al.
BRITISH JOURNAL OF CANCER (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Sphingosine 1-phosphate signalling in mammalian cells
S Pyne et al.
BIOCHEMICAL JOURNAL (2000)
Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
P Gerwins et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Share Paper
